Percentage of Participants With an Occurrence of Biopsy Proven Acute Rejection (BPAR) During the First 3 Months Post de Novo Liver Transplantation. Month 3 [clinicaltrials_resource:a73af65863fc6f7f9d9d5925b4a60dbc]
A BPAR is defined when the investigator had a suspicion of an acute rejection, where the final clinical diagnosis confirmed the occurrence of an acute rejection, where a biopsy was performed that confirmed the presence of an acute rejection, and where anti-rejection treatment intervention was initiated. The efficacy measured the first rejections (clinically and biopsy proven rejections) at 3 months.
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
Percentage of Participants With an Occurrence of Biopsy Proven Acute Rejection (BPAR) During the First 3 Months Post de Novo Liver Transplantation. Month 3 [clinicaltrials_resource:a73af65863fc6f7f9d9d5925b4a60dbc]
A BPAR is defined when the investigator had a suspicion of an acute rejection, where the final clinical diagnosis confirmed the occurrence of an acute rejection, where a biopsy was performed that confirmed the presence of an acute rejection, and where anti-rejection treatment intervention was initiated. The efficacy measured the first rejections (clinically and biopsy proven rejections) at 3 months.
Bio2RDF identifier
a73af65863fc6f7f9d9d5925b4a60dbc
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:a73af65863fc6f7f9d9d5925b4a60dbc
measure [clinicaltrials_vocabulary:measure]
Percentage of Participants Wit ...... de Novo Liver Transplantation.
time frame [clinicaltrials_vocabulary:time-frame]
description
A BPAR is defined when the inv ...... roven rejections) at 3 months.
identifier
clinicaltrials_resource:a73af65863fc6f7f9d9d5925b4a60dbc
title
Percentage of Participants Wit ...... Liver Transplantation. Month 3
@en
type
label
Percentage of Participants Wit ...... af65863fc6f7f9d9d5925b4a60dbc]
@en